Symbols / VEEV
VEEV Chart
About
Veeva Systems Inc. provides cloud-based software for the life sciences industry in North America, Europe, the Asia Pacific, the Middle East, Africa, and Latin America. The company offers Veeva Commercial Cloud comprising Veeva Vault CRM Suite for pharmaceutical and biotechnology companies; Veeva Medical that provides source of medical content across multiple channels and geographies; Veeva PromoMats, an end-to-end content and digital asset management solution; and Veeva Crossix, an analytics platform for pharmaceutical brands. It also provides Veeva Data Cloud consisting of Veeva OpenData, a customer reference data solution; Veeva Link, which provides deep data; Veeva Compass, which includes de-identified and longitudinal patient data; and Veeva CRM Pulse that provides access and multichannel engagement metrics. In addition, the company offers Veeva Development Cloud consisting of Veeva Clinical Platform, which advances clinical trial execution; Veeva Clinical Data Management that helps sponsors and CROs design and run trials; Veeva Safety, which unifies systems and processes; and Veeva RIM that provides regulatory information management capabilities; as well as Veeva Quality Cloud, which is used by the life sciences and consumer products industries; and Veeva Business Consulting services. Further, it provides professional and support services, including implementation and deployment planning, and project management; requirements analysis, solution design, and configuration; systems environment management and deployment; services focused on advancing or transforming business and operating processes; technical consulting services on data migration and systems integrations; training; and ongoing managed services, such as outsourced systems administration. The company was formerly known as Verticals onDemand, Inc. and changed its name to Veeva Systems Inc. in April 2009. Veeva Systems Inc. was incorporated in 2007 and is headquartered in Pleasanton, California.
Fundamentals
Scroll to Statements| Sector | Healthcare | Industry | Health Information Servi | Market Cap | 31.44B |
| Enterprise Value | 25.68B | Income | 908.91M | Sales | 3.20B |
| Book/sh | 43.90 | Cash/sh | 39.92 | Dividend Yield | — |
| Payout | 0.00% | Employees | — | IPO | — |
| P/E | 35.15 | Forward P/E | 19.33 | PEG | — |
| P/S | 9.84 | P/B | 4.36 | P/C | — |
| EV/EBITDA | 26.07 | EV/Sales | 8.04 | Quick Ratio | 4.81 |
| Current Ratio | 4.88 | Debt/Eq | 1.33 | LT Debt/Eq | — |
| EPS (ttm) | 5.44 | EPS next Y | 9.89 | EPS Growth | 23.50% |
| Revenue Growth | 16.00% | Earnings | 2026-05-27 | ROA | 7.25% |
| ROE | 13.93% | ROIC | — | Gross Margin | 75.53% |
| Oper. Margin | 29.41% | Profit Margin | 28.44% | Shs Outstand | 164.38M |
| Shs Float | 150.86M | Short Float | 4.21% | Short Ratio | 2.67 |
| Short Interest | — | 52W High | 310.50 | 52W Low | 168.14 |
| Beta | 1.12 | Avg Volume | 2.11M | Volume | 812.61K |
| Target Price | $275.43 | Recom | Buy | Prev Close | $195.57 |
| Price | $191.24 | Change | -2.22% |
Valuation Models
Price estimates from analyst targets and simple models.
1. Analyst consensus
$275.43
Mean price target
2. Current target
$191.24
Latest analyst target
3. DCF / Fair value
$114.76
Simplified: (Free Cash Flow ÷ Shares) × 18 (P/FCF multiple). Not a …
Ratings
Current target
$191.24
Low
$190.00
High
$350.00
Mean
$275.43
Latest analyst rating changes
| Date | Action | Analyst | Rating Change | Price Target |
|---|---|---|---|---|
| 2026-03-09 | main | Citigroup | Buy → Buy | $291 |
| 2026-03-05 | main | Canaccord Genuity | Hold → Hold | $235 |
| 2026-03-05 | main | TD Cowen | Buy → Buy | $300 |
| 2026-03-05 | main | Wells Fargo | Overweight → Overweight | $317 |
| 2026-03-05 | main | Stifel | Buy → Buy | $245 |
| 2026-03-05 | reit | Truist Securities | Buy → Buy | $262 |
| 2026-03-05 | main | RBC Capital | Outperform → Outperform | $275 |
| 2026-03-05 | main | UBS | Neutral → Neutral | $220 |
| 2026-03-05 | main | Evercore ISI Group | In-Line → In-Line | $240 |
| 2026-03-05 | main | Morgan Stanley | Equal-Weight → Equal-Weight | $215 |
| 2026-03-05 | main | Needham | Buy → Buy | $270 |
| 2026-03-05 | main | Piper Sandler | Overweight → Overweight | $285 |
| 2026-02-26 | main | Stifel | Buy → Buy | $212 |
| 2026-02-25 | main | Barclays | Overweight → Overweight | $250 |
| 2026-02-24 | main | Oppenheimer | Outperform → Outperform | $275 |
| 2026-02-20 | main | JP Morgan | Overweight → Overweight | $296 |
| 2026-02-20 | main | UBS | Neutral → Neutral | $200 |
| 2026-02-17 | up | Morgan Stanley | Underweight → Equal-Weight | $205 |
| 2025-12-12 | down | Keybanc | Overweight → Sector Weight | — |
| 2025-11-25 | main | Wells Fargo | Overweight → Overweight | $333 |
- Veeva spends $100M on AI chat that gives patients instant answers - Stock Titan ue, 10 Mar 2026 15
- Veeva Systems slips as post-earnings price-target cuts weigh on sentiment - Quiver Quantitative ue, 10 Mar 2026 15
- Russell Investments Group Ltd. Purchases 16,628 Shares of Veeva Systems Inc. $VEEV - MarketBeat ue, 10 Mar 2026 10
- AOP Health unifies rare-disease R&D, safety and sales on Veeva - Stock Titan ue, 10 Mar 2026 13
- Veeva Acquires Ostro to Enhance Brand Engagement - Intellectia AI ue, 10 Mar 2026 15
- Veeva Systems (NYSE:VEEV) Delivers Strong Q4 CY2025 Numbers, Stock Soars - Yahoo Finance Wed, 04 Mar 2026 21
- Veeva Systems Stock Pre-Market (+11%): Reports Strong Earnings Beat & Raise - Trefis hu, 05 Mar 2026 15
- Biggest stock movers Thursday: AVGO, TTD, CIEN, AEO, and more - Seeking Alpha hu, 05 Mar 2026 15
- 2 Growth Stocks Set to Flourishand 1 Facing Challenges - Finviz Mon, 09 Mar 2026 20
- Citigroup Issues Pessimistic Forecast for Veeva Systems (NYSE:VEEV) Stock Price - MarketBeat Mon, 09 Mar 2026 15
- Is It Time To Revisit Veeva Systems (VEEV) After Recent Share Price Swings? - Yahoo Finance Wed, 04 Mar 2026 19
- Schroder Investment Management Group Boosts Stock Holdings in Veeva Systems Inc. $VEEV - MarketBeat Mon, 09 Mar 2026 12
- Veeva Systems Inc. $VEEV Shares Purchased by Goodman Advisory Group LLC - MarketBeat Sun, 08 Mar 2026 09
- First Trust Advisors LP Buys 29,869 Shares of Veeva Systems Inc. $VEEV - MarketBeat Sun, 08 Mar 2026 09
- Quantbot Technologies LP Sells 36,891 Shares of Veeva Systems Inc. $VEEV - MarketBeat Mon, 09 Mar 2026 09
Insider Transactions
| Date | Shares | Value | Url | Text | Insider | Position | Transaction | Start Date | Ownership |
|---|---|---|---|---|---|---|---|---|---|
| 0 | 1000 | 200000.0 | — | Sale at price 200.00 per share. | SCHWENGER THOMAS D | President | — | 2026-03-05 00:00:00 | D |
| 1 | 288 | nan | — | — | MOHR MARSHALL L | Director | — | 2026-02-27 00:00:00 | D |
| 2 | 271 | nan | — | — | CARGES MARK T | Director | — | 2026-02-27 00:00:00 | D |
| 3 | 253 | nan | — | — | SEKHRI PAUL JAI | Director | — | 2026-02-27 00:00:00 | D |
| 4 | 253 | nan | — | — | WALLACH MATTHEW J | Director | — | 2026-02-27 00:00:00 | D |
| 5 | 262 | nan | — | — | CABRAL TIMOTHY S | Director | — | 2026-02-27 00:00:00 | D |
| 6 | 297 | nan | — | — | RITTER GORDON | Director | — | 2026-02-27 00:00:00 | D |
| 7 | 262 | nan | — | — | HUNG PRISCILLA C | Director | — | 2026-02-27 00:00:00 | D |
| 8 | 262 | nan | — | — | HEDLEY MARY LYNNE | Director | — | 2026-02-27 00:00:00 | D |
| 9 | 1000 | 231430.0 | — | Sale at price 231.43 per share. | SCHWENGER THOMAS D | President | — | 2026-01-13 00:00:00 | D |
Financials
| Line Item | 2025-01-31 | 2024-01-31 | 2023-01-31 | 2022-01-31 |
|---|---|---|---|---|
| TaxEffectOfUnusualItems | -730.10K | 13.14K | 24.83K | -118.35K |
| TaxRateForCalcs | 0.22 | 0.11 | 0.04 | 0.17 |
| NormalizedEBITDA | 734.09M | 461.84M | 487.62M | 533.66M |
| TotalUnusualItems | -3.27M | 124.00K | 591.00K | -714.00K |
| TotalUnusualItemsExcludingGoodwill | -3.27M | 124.00K | 591.00K | -714.00K |
| NetIncomeFromContinuingOperationNetMinorityInterest | 714.14M | 525.71M | 487.71M | 427.39M |
| ReconciledDepreciation | 39.38M | 32.63M | 29.12M | 27.45M |
| ReconciledCostOfRevenue | 699.64M | 677.29M | 609.40M | 503.68M |
| EBITDA | 730.82M | 461.96M | 488.21M | 532.94M |
| EBIT | 691.43M | 429.33M | 459.09M | 505.50M |
| NetInterestIncome | 207.99M | 133.75M | 45.86M | 14.73M |
| InterestIncome | 207.99M | 133.75M | 45.86M | 14.73M |
| NormalizedIncome | 716.68M | 525.59M | 487.14M | 427.99M |
| NetIncomeFromContinuingAndDiscontinuedOperation | 714.14M | 525.71M | 487.71M | 427.39M |
| TotalExpenses | 2.06B | 1.93B | 1.70B | 1.35B |
| TotalOperatingIncomeAsReported | 691.43M | 429.33M | 459.09M | 505.50M |
| DilutedAverageShares | 167.00M | 165.23M | 163.49M | 162.44M |
| BasicAverageShares | 163.67M | 161.88M | 160.53M | 155.38M |
| DilutedEPS | 5.44 | 4.32 | 3.22 | 3.00 |
| BasicEPS | 5.55 | 4.41 | 3.27 | 3.14 |
| DilutedNIAvailtoComStockholders | 714.14M | 525.71M | 487.71M | 427.39M |
| NetIncomeCommonStockholders | 714.14M | 525.71M | 487.71M | 427.39M |
| NetIncome | 714.14M | 525.71M | 487.71M | 427.39M |
| NetIncomeIncludingNoncontrollingInterests | 714.14M | 525.71M | 487.71M | 427.39M |
| NetIncomeContinuousOperations | 714.14M | 525.71M | 487.71M | 427.39M |
| TaxProvision | 205.24M | 62.32M | 21.39M | 84.92M |
| PretaxIncome | 919.38M | 588.02M | 509.10M | 512.31M |
| OtherIncomeExpense | 19.96M | 24.94M | 4.14M | -7.92M |
| OtherNonOperatingIncomeExpenses | 611.00K | 572.00K | ||
| SecuritiesAmortization | -22.62M | -24.82M | -2.98M | 7.20M |
| GainOnSaleOfSecurity | -3.27M | 124.00K | 591.00K | -714.00K |
| NetNonOperatingInterestIncomeExpense | 207.99M | 133.75M | 45.86M | 14.73M |
| InterestIncomeNonOperating | 207.99M | 133.75M | 45.86M | 14.73M |
| OperatingIncome | 691.43M | 429.33M | 459.09M | 505.50M |
| OperatingExpense | 1.36B | 1.26B | 1.09B | 841.60M |
| ResearchAndDevelopment | 693.08M | 629.03M | 520.28M | 382.04M |
| SellingGeneralAndAdministration | 662.47M | 628.02M | 566.29M | 459.57M |
| SellingAndMarketingExpense | 396.73M | 381.47M | 348.69M | 288.06M |
| GeneralAndAdministrativeExpense | 265.74M | 246.54M | 217.59M | 171.51M |
| OtherGandA | 265.74M | 246.54M | 217.59M | 171.51M |
| GrossProfit | 2.05B | 1.69B | 1.55B | 1.35B |
| CostOfRevenue | 699.64M | 677.29M | 609.40M | 503.68M |
| TotalRevenue | 2.75B | 2.36B | 2.16B | 1.85B |
| OperatingRevenue | 2.75B | 2.36B | 2.16B | 1.85B |
| Line Item | 2025-01-31 | 2024-01-31 | 2023-01-31 | 2022-01-31 |
|---|---|---|---|---|
| OrdinarySharesNumber | 162.58M | 161.26M | 158.24M | 154.20M |
| ShareIssued | 162.58M | 161.26M | 158.24M | 154.20M |
| TotalDebt | 75.78M | 55.77M | 60.98M | 54.59M |
| TangibleBookValue | 5.35B | 4.14B | 3.19B | 2.37B |
| InvestedCapital | 5.83B | 4.64B | 3.72B | 2.91B |
| WorkingCapital | 4.91B | 3.82B | 2.96B | 2.27B |
| NetTangibleAssets | 5.35B | 4.14B | 3.19B | 2.37B |
| CapitalLeaseObligations | 75.78M | 55.77M | 60.98M | 54.59M |
| CommonStockEquity | 5.83B | 4.64B | 3.72B | 2.91B |
| TotalCapitalization | 5.83B | 4.64B | 3.72B | 2.91B |
| TotalEquityGrossMinorityInterest | 5.83B | 4.64B | 3.72B | 2.91B |
| StockholdersEquity | 5.83B | 4.64B | 3.72B | 2.91B |
| GainsLossesNotAffectingRetainedEarnings | -8.42M | -10.64M | -31.13M | -11.96M |
| OtherEquityAdjustments | -8.42M | -10.64M | -31.13M | -11.96M |
| RetainedEarnings | 3.45B | 2.74B | 2.21B | 1.73B |
| AdditionalPaidInCapital | 2.39B | 1.92B | 1.53B | 1.20B |
| CapitalStock | 2.00K | 2.00K | 2.00K | 2.00K |
| CommonStock | 2.00K | 2.00K | 2.00K | 2.00K |
| TotalLiabilitiesNetMinorityInterest | 1.51B | 1.27B | 1.09B | 904.83M |
| TotalNonCurrentLiabilitiesNetMinorityInterest | 108.98M | 87.21M | 81.24M | 64.05M |
| OtherNonCurrentLiabilities | 42.59M | 38.72M | 30.08M | 18.23M |
| NonCurrentDeferredLiabilities | 587.00K | 2.05M | 1.49M | 2.22M |
| NonCurrentDeferredTaxesLiabilities | 587.00K | 2.05M | 1.49M | 2.22M |
| LongTermDebtAndCapitalLeaseObligation | 65.81M | 46.44M | 49.67M | 43.61M |
| LongTermCapitalLeaseObligation | 65.81M | 46.44M | 49.67M | 43.61M |
| CurrentLiabilities | 1.40B | 1.18B | 1.01B | 840.78M |
| CurrentDeferredLiabilities | 1.27B | 1.05B | 869.28M | 731.75M |
| CurrentDeferredRevenue | 1.27B | 1.05B | 869.28M | 731.75M |
| CurrentDebtAndCapitalLeaseObligation | 9.97M | 9.33M | 11.31M | 10.98M |
| CurrentCapitalLeaseObligation | 9.97M | 9.33M | 11.31M | 10.98M |
| PensionandOtherPostRetirementBenefitPlansCurrent | 18.80M | 19.76M | 16.81M | 15.79M |
| PayablesAndAccruedExpenses | 95.65M | 100.03M | 109.40M | 82.26M |
| CurrentAccruedExpenses | 28.48M | 28.63M | 30.70M | 28.40M |
| Payables | 67.18M | 71.40M | 78.70M | 53.86M |
| OtherPayable | 6.41M | 6.56M | 6.65M | 6.52M |
| TotalTaxPayable | 30.32M | 33.32M | 30.37M | 26.99M |
| IncomeTaxPayable | 9.02M | 11.86M | 4.95M | 7.76M |
| AccountsPayable | 30.45M | 31.51M | 41.68M | 20.35M |
| TotalAssets | 7.34B | 5.91B | 4.80B | 3.82B |
| TotalNonCurrentAssets | 1.03B | 907.71M | 834.98M | 709.28M |
| OtherNonCurrentAssets | 56.54M | 43.30M | 38.95M | 25.13M |
| NonCurrentDeferredAssets | 370.30M | 257.38M | 168.52M | 38.20M |
| NonCurrentDeferredTaxesAssets | 343.92M | 233.46M | 136.70M | 5.10M |
| GoodwillAndOtherIntangibleAssets | 484.34M | 502.89M | 522.35M | 541.82M |
| OtherIntangibleAssets | 44.46M | 63.02M | 82.48M | 101.94M |
| Goodwill | 439.88M | 439.88M | 439.88M | 439.88M |
| NetPPE | 119.78M | 104.13M | 105.15M | 104.14M |
| AccumulatedDepreciation | -31.45M | -36.76M | -32.12M | -30.27M |
| GrossPPE | 151.23M | 140.89M | 137.27M | 134.41M |
| Leases | 30.19M | 30.79M | 18.99M | 19.00M |
| ConstructionInProgress | 2.99M | 31.00K | 302.00K | 730.00K |
| OtherProperties | 55.34M | 49.64M | ||
| MachineryFurnitureEquipment | 7.77M | 18.05M | 16.23M | 18.62M |
| BuildingsAndImprovements | 84.85M | 66.59M | 76.32M | 20.98M |
| LandAndImprovements | 25.43M | 25.43M | 25.43M | 25.43M |
| Properties | 0.00 | 0.00 | 0.00 | 0.00 |
| CurrentAssets | 6.31B | 5.00B | 3.97B | 3.11B |
| OtherCurrentAssets | 101.46M | 86.92M | 81.46M | 36.68M |
| PrepaidAssets | 36.68M | |||
| Receivables | 1.06B | 888.54M | 785.23M | 694.40M |
| OtherReceivables | 40.76M | 36.37M | 82.17M | 63.27M |
| AccountsReceivable | 1.02B | 852.17M | 703.05M | 631.13M |
| AllowanceForDoubtfulAccountsReceivable | -57.00K | -520.00K | -469.00K | -473.00K |
| GrossAccountsReceivable | 1.02B | 852.69M | 703.52M | 631.61M |
| CashCashEquivalentsAndShortTermInvestments | 5.15B | 4.03B | 3.10B | 2.38B |
| OtherShortTermInvestments | 4.03B | 3.32B | 2.22B | 1.24B |
| CashAndCashEquivalents | 1.12B | 703.49M | 886.47M | 1.14B |
| Line Item | 2025-01-31 | 2024-01-31 | 2023-01-31 | 2022-01-31 |
|---|---|---|---|---|
| FreeCashFlow | 1.09B | 911.34M | 780.47M | 764.46M |
| IncomeTaxPaidSupplementalData | 322.05M | 134.47M | 167.95M | 58.63M |
| EndCashPosition | 1.12B | 706.67M | 889.65M | 1.14B |
| BeginningCashPosition | 706.67M | 889.65M | 1.14B | 731.71M |
| EffectOfExchangeRateChanges | -1.74M | -1.78M | -4.99M | -4.66M |
| ChangesInCash | 416.03M | -181.20M | -246.59M | 414.17M |
| FinancingCashFlow | 26.11M | -16.19M | -19.38M | -4.14M |
| CashFlowFromContinuingFinancingActivities | 26.11M | -16.19M | -19.38M | -4.14M |
| NetOtherFinancingCharges | -79.42M | -78.88M | -63.03M | -55.29M |
| ProceedsFromStockOptionExercised | 105.54M | 62.69M | 43.65M | 51.54M |
| NetIssuancePaymentsOfDebt | 0.00 | 0.00 | -384.00K | |
| NetLongTermDebtIssuance | 0.00 | 0.00 | -384.00K | |
| InvestingCashFlow | -700.14M | -1.08B | -1.01B | -346.15M |
| CashFlowFromContinuingInvestingActivities | -700.14M | -1.08B | -1.01B | -346.15M |
| NetOtherInvestingChanges | -20.52M | -26.20M | -13.51M | -14.21M |
| NetInvestmentPurchaseAndSale | -679.62M | -1.05B | -994.17M | -324.16M |
| SaleOfInvestment | 1.90B | 1.65B | 1.00B | 792.92M |
| PurchaseOfInvestment | -2.58B | -2.70B | -2.00B | -1.12B |
| NetBusinessPurchaseAndSale | 0.00 | 0.00 | -7.78M | |
| PurchaseOfBusiness | 0.00 | 0.00 | -7.78M | |
| OperatingCashFlow | 1.09B | 911.34M | 780.47M | 764.46M |
| CashFlowFromContinuingOperatingActivities | 1.09B | 911.34M | 780.47M | 764.46M |
| ChangeInWorkingCapital | 7.62M | 60.82M | 7.34M | 20.66M |
| ChangeInOtherWorkingCapital | 209.84M | 177.90M | 119.66M | 99.06M |
| ChangeInOtherCurrentLiabilities | -9.59M | -5.92M | -1.72M | -4.13M |
| ChangeInPayablesAndAccruedExpense | -6.21M | -7.56M | 27.89M | 11.72M |
| ChangeInAccruedExpense | -1.41M | -4.25M | 9.28M | 9.44M |
| ChangeInPayable | -4.80M | -3.31M | 18.61M | 2.28M |
| ChangeInAccountPayable | -1.96M | -10.23M | 21.43M | -3.00M |
| ChangeInTaxPayable | -2.84M | 6.92M | -2.81M | 5.28M |
| ChangeInIncomeTaxPayable | -2.84M | 6.92M | -2.81M | 5.28M |
| ChangeInPrepaidAssets | -17.45M | 414.00K | -47.40M | -2.91M |
| ChangeInReceivables | -168.97M | -104.00M | -91.08M | -83.08M |
| ChangesInAccountReceivables | -164.57M | -149.81M | -72.18M | -67.02M |
| OtherNonCashItems | 28.28M | 30.34M | 35.52M | 37.49M |
| StockBasedCompensation | 437.35M | 393.73M | 351.91M | 234.64M |
| AssetImpairmentCharge | 693.00K | 256.00K | 272.00K | |
| AmortizationOfSecurities | -24.44M | -26.52M | -3.62M | 6.26M |
| DeferredTax | -112.27M | -105.37M | -127.50M | 11.08M |
| DeferredIncomeTax | -112.27M | -105.37M | -127.50M | 11.08M |
| DepreciationAmortizationDepletion | 39.38M | 32.63M | 29.12M | 27.45M |
| DepreciationAndAmortization | 39.38M | 32.63M | 29.12M | 27.45M |
| OperatingGainsLosses | -222.00K | 971.00K | -782.00K | |
| NetForeignCurrencyExchangeGainLoss | -222.00K | 971.00K | -782.00K | |
| NetIncomeFromContinuingOperations | 714.14M | 525.71M | 487.71M | 427.39M |
SEC Filings
Recent 10-K, 10-Q, 8-K, and Form 4 (insider) filings.
Public Trades for VEEV
| Date | User | Asset | Broker | Type | Position Size | Entry Price | Patterns |
|---|